Looks like there is significant drop in meropenem prices which is one of the key product for Gufic criticare division. Innovator Pfizer brand Meronem 1gm is available at MRP of 1067.00 which use to be 2-3 times higher few quarters back. Usually innovator brand commands some premium over other generics. When Meronem is available at such price, other generics brand companies also start adjusting their price. Gufic was negotiating with Govt for higher price of 40-50% to launch their dual chamber meropenem. Q3 concall may provide some insights on the same.
Management view from Q2 concall:
Subscribe To Our Free Newsletter |